CRISPR and another genetic strategy fix cell defects in two common blood disorders
It is a double milestone: new evidence that cures are possible for many people born with sickle cell disease and another serious blood disorder, beta-thalassemia, and a first for the genome editor CRISPR.
No comments:
Post a Comment